• No results found

The Aon Benfield Aggregate

N/A
N/A
Protected

Academic year: 2021

Share "The Aon Benfield Aggregate"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

(1)

The Aon Benfield

Aggregate

Nine months ended September 30, 2010

(2)

Global (Re)insurer Capital

(再)保険者の資本推移

-17%

18%

17%

0

50

100

150

200

250

300

350

400

450

500

2007

2008

2009

9M 2010

US

Db

n

(3)

P&C Gross Premiums Written, % change

グロス計上保険料(損保)増収率

-0.1% -30% -20% -10% 0% 10% 20% 30% 40% 50% Argo Group Platinum Swiss Re Arch Capital National Indemnity RenaissanceRe American Agricultural White Mountains Dorinco Gen Re Transatlantic Holdings XL Group ABA Aspen Allied World ACE Munich Re Endurance Specialty Everest Re Axis Capital Alterra Fairfax Hannover Re SCOR Flagstone Re Montpelier Re Maiden Validus PartnerRe Greenlight Re Starr Indemnity

% Change in P&C Gross Premiums Written (Reporting Currency)

(4)

Distribution of Net Premiums Written

正味計上保険料の会社別内訳

9M 2010 P&C Net Premiums Written

USD87bn

Munich Re 22.4%

ACE 10.6%

Swiss Re 10.1%

Hannover Re 6.6%

XL Group 4.5%

National Indemnity 4.3%

Fairfax 3.9%

PartnerRe 3.9%

SCOR 3.9%

Everest Re 3.5%

Remainder 26.3%

(5)

ABA Pre-Tax Profit ABA

税引前利益

17.6

23.0

-20

-10

0

10

20

30

40

9M 2009

9M 2010

P

re

-t

a

x

pr

of

it U

S

D

b

n

Other

Capital gains/losses

Life underwriting result

Non-life underwriting result

Investment income

Pre-tax profit

その他 投資収益 生保引受利益 キャピタル・ゲイン(ロス) 損保引受利益 税引前利益

(6)

Pre-Tax Profits, % change

税引前利益増加率

31% -100% -50% 0% 50% 100% 150% 200% White Mountains Greenlight Re Flagstone Re Validus Montpelier Re Everest Re Aspen PartnerRe Endurance Specialty Transatlantic Holdings Fairfax Platinum RenaissanceRe Munich Re Hannover Re Arch Capital Argo Group Dorinco Maiden Alterra Allied World ABA ACE SCOR Gen Re Starr Indemnity American Agricultural Axis Capital XL Group Swiss Re National Indemnity

% Change in 9M 2010/09 Pre-tax Profit (Reporting Currency)

1150% 816% 513%

(7)

ABA Combined Ratio ABA

コンバインド・レシオ

-3.4%

30.2%

96.8%

29.3%

71.1%

-4.5%

65.2%

91.1%

-10%

10%

30%

50%

70%

90%

110%

9M 2009 COR

Expense ratio

Loss ratio

Prior year reserve adj

9M 2010 COR

2009年9月末

コンバインド・レシオ 事業費率

損害率 過年度リザーブ調整額 2010年9月末 コンバインド・レシオ

(8)

Combined Ratios

コンバインド・レシオ

96.8% 50% 70% 90% 110% RenaissanceRe Platinum Montpelier Re Dorinco Allied World Alterra National Indemnity Axis Capital Endurance Specialty ACE Gen Re Validus Arch Capital PartnerRe Swiss Re XL Group Maiden ABA Aspen SCOR Hannover Re Transatlantic Holdings Flagstone Re Munich Re Greenlight Re White Mountains Argo Group Everest Re American Agricultural Fairfax Starr Indemnity
(9)

Loss Reserve Development

ロス・リザーブ調整

4.5% -10% 0% 10% 20% 30% 40% Greenlight Re Maiden SCOR Munich Re Starr Indemnity Aspen Transatlantic Holdings Swiss Re Fairfax Everest Re American Agricultural Argo Group White Mountains Hannover Re Flagstone Re ABA ACE Arch Capital XL Group Endurance Specialty Dorinco Alterra Validus Axis Capital PartnerRe National Indemnity Montpelier Re Gen Re Platinum Allied World RenaissanceRe

Prior Year Reserve Adj as % of NPE (Reporting Currency)

(10)

Investment Return

投資利回り

4.9% 0% 2% 4% 6% 8% 10% American Agricultural XL Group Starr Indemnity SCOR Endurance Specialty Alterra Hannover Re Greenlight Re White Mountains Maiden Transatlantic Holdings Argo Group Flagstone Re Aspen Swiss Re ACE Dorinco Everest Re Axis Capital Arch Capital ABA Platinum Validus Munich Re Montpelier Re Gen Re National Indemnity PartnerRe RenaissanceRe Allied World Fairfax
(11)

Shareholders’ Funds Development – 9M 2010 vs 9M 2009

株主資本推移

164.0

4.0

13.6

-3.7

3.2

20.2

-0.6

1.7

202.4

150

170

190

210

FY 2008

SHF

Additional

capital

Net income Dividends

FX

Investment

gains

Share

buybacks

Other

9M 2009

SHF

US

D b

n

209.8

25.2

19.1

-4.4

-1.5

11.2

-6.5

-1.9

251.0

180

200

220

240

260

FY 2009

SHF

Additional

capital

Net income Dividends

FX

Investment

gains

Share

buybacks

Other

9M 2010

SHF

US

D b

n

前年末 株主資本 追加資本 純利益 配当 為替 投資利益 自社株買戻し その他 9月末 株主資本 20101~920091~9
(12)

Shareholders’ Funds, % change

株主資本増加率

20% -10% 10% 30% 50% 70% 90% Validus Montpelier Re Dorinco PartnerRe White Mountains Flagstone Re Starr Indemnity American Agricultural Everest Re Gen Re RenaissanceRe Argo Group Allied World Aspen Platinum Endurance Specialty Greenlight Re Axis Capital Transatlantic Holdings Munich Re Arch Capital SCOR Maiden XL Group ACE Fairfax ABA Hannover Re Swiss Re National Indemnity Alterra
(13)

Invested Assets

運用資産内訳

66%

12%

7%

15%

ABA Invested Assets

31 December 2009 USD844bn

Fixed income securities

Equities

Cash

Other

63%

11%

6%

20%

ABA Invested Assets

30 September 2010 USD900bn

(14)

Contact List

Jonathan Eggins

Aon Benfield Research

+44.207.522.3898

jonathan.eggins@aonbenfield.com

Aon Benfield Research

+44.207.522.3823

References

Related documents

Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.

Despite morphological and cytological differences between two weedy Sonchus species (S. oleraceus), gene content and arrangement were found to be identical in five chloroplast genomes,

In answer to these questions, this paper offers two main reasons for the relative neglect of this motivational component: the first is related to the histori- cal roots of the

Given the level of aggregation of technological classes on which we computed the Herfindahl indexes, these results may also suggest that only in very diversified sectors like the

The students will be tasked to perform a choral reading on the poem ‘’The Road Not Taken’’.. After the choral reading, each group will give their interpretation about

daily press review, daily news summary, daily news digest, media alerts, thematic media review, weekly previews and daily social media summaries deliverable on working days

Confident that I could substantially increase sales, I accepted the request from James Manktelow, the CEO and co-founder of Mind Tools, to completely reimagine

A look at table 4.11 indicates that there is a long term positive association between private manufacturing value added as a whole and public investment and real